{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:49:39Z","timestamp":1774532979100,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T00:00:00Z","timestamp":1346976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-104","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T10:14:43Z","timestamp":1347012883000},"source":"Crossref","is-referenced-by-count":7,"title":["Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP)"],"prefix":"10.1186","volume":"13","author":[{"name":"KEEP investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhasish","family":"Bose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S","family":"Bomback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal N","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"issue":"2 suppl 1","key":"348_CR1","first-page":"S1\u2013S266","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation: K\/DOQI clinical practice guidelines for chronic kidneydisease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 suppl 1): S1\u2013S266-","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"348_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3810\/pgm.2010.03.2119","volume":"122","author":"PA McCullough","year":"2010","unstructured":"McCullough PA, Verril TA: Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. Postgrad Med. 2010, 122 (2): 25-34. 10.3810\/pgm.2010.03.2119.","journal-title":"Postgrad Med"},{"issue":"1","key":"348_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2007.06.018","volume":"197","author":"IH de Boer","year":"2008","unstructured":"de Boer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B: Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2008, 197 (1): 407-414. 10.1016\/j.atherosclerosis.2007.06.018. Epub 2007 Aug 6","journal-title":"Atherosclerosis"},{"issue":"9","key":"348_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/BF03346530","volume":"32","author":"RA Al-Salman","year":"2009","unstructured":"Al-Salman RA, Al-Basri HA, Al-Sayyad AS, Hearnshaw HM: Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain. J Endocrinol Invest. 2009, 32 (9): 746-751.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"348_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1472-6963-8-226","volume":"5","author":"C Meisinger","year":"2008","unstructured":"Meisinger C, Heier M, Landgraf R, Happich M, Wichmann HE, Piehlmeier W: Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study. BMC Health Serv Res. 2008, 5 (8): 226-","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"348_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1523-1755.2005.00235.x","volume":"67","author":"CH Tseng","year":"2005","unstructured":"Tseng CH: Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients. Kidney Int. 2005, 67 (4): 1547-1553. 10.1111\/j.1523-1755.2005.00235.x.","journal-title":"Kidney Int"},{"issue":"10","key":"348_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/j.1464-5491.2008.02534.x","volume":"25","author":"C Daousi","year":"2008","unstructured":"Daousi C, Bain SC, Barnett AH, Gill GV: Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes. Diabet Med. 2008, 25 (10): 1234-1236. 10.1111\/j.1464-5491.2008.02534.x.","journal-title":"Diabet Med"},{"issue":"1","key":"348_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0272-6386(03)00405-0","volume":"42","author":"WW Brown","year":"2003","unstructured":"Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen S-C, King K, Klag M, Molony DA, Flack JM: Early detection of kidney disease in community settings: the kidney early evaluation program. Am J Kidney Dis. 2003, 42 (1): 22-35. 10.1016\/S0272-6386(03)00405-0.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"348_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semnephrol.2009.10.004","volume":"30","author":"JA Vassalotti","year":"2010","unstructured":"Vassalotti JA, Li S, McCullough PA, Barkis G: Kidney early evaluation program: a community based screening approach to address disparity in chronic kidney disease. Semin Nephrol. 2010, 30 (1): 66-73. 10.1016\/j.semnephrol.2009.10.004.","journal-title":"Semin Nephrol"},{"issue":"No 3, Suppl 2","key":"348_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1053\/j.ajkd.2009.10.045","volume":"55","author":"AS Bomback","year":"2010","unstructured":"Bomback AS, Kshirsagar AV, Whaley-Connell AT, Chen S, Li S, Klemmer PJ, McCullough PA, Barkis G: Racial differences in Kidney function among individuals withobesity and metabolic syndrome: results from the Kidney Early Evaluation Program. Am J Kidney Dis. 2010, 55 (No 3, Suppl 2): S4-S14. 10.1053\/j.ajkd.2009.10.045.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"348_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1751-7176.2009.00190.x","volume":"12","author":"A Whaley-Connell","year":"2010","unstructured":"Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane SI, Chen S, Vassalotti JA, Collins AJ, Bakris G, Sowers J: Dysglycemia predicts cardiovascular and kidney disease in Kidney Early Evaluation Program. J Clin Hypertens. 2010, 12 (1): 51-58. 10.1111\/j.1751-7176.2009.00190.x.","journal-title":"J Clin Hypertens"},{"issue":"4 suppl 2","key":"348_CR12","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1053\/j.ajkd.2007.12.016","volume":"51","author":"AT Whaley-Connell","year":"2008","unstructured":"Whaley-Connell AT, Sowers JR, Stevens LA, et al: Kidney Early Evaluation Program Investigators. CKD in the United States: Kidney Early EvaluationProgram (KEEP) and National Health and Nutrition Examination Survey(NHANES) 1999\u20132004. Am J Kidney Dis. 2008, 51 (4 suppl 2): S13-S20.","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"348_CR13","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1053\/j.ajkd.2008.01.001","volume":"51","author":"LA Stevens","year":"2008","unstructured":"Stevens LA, Stoycheff N: Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008, 51 (suppl 2): S77-S82.","journal-title":"Am J Kidney Dis"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.2337\/dc07-0387","volume":"30","author":"CK Kramer","year":"2007","unstructured":"Kramer CK, Leitao CB, Pinto LC, et al: Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Diabetes Care. 2007, 30: 1998-2000. 10.2337\/dc07-0387.","journal-title":"Diabetes Care"},{"key":"348_CR15","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","volume":"61","author":"AX Garg","year":"2002","unstructured":"Garg AX, Kiberd BA, Clark WF, et al: Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002, 61: 2165-2175. 10.1046\/j.1523-1755.2002.00356.x.","journal-title":"Kidney Int"},{"key":"348_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2004.07.021","volume":"67","author":"J Cederholm","year":"2005","unstructured":"Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S: For the Steering Committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract. 2005, 67: 258-266. 10.1016\/j.diabres.2004.07.021.","journal-title":"Diabetes Res Clin Pract"},{"key":"348_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986.","journal-title":"N Engl J Med"},{"key":"348_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853.","journal-title":"Lancet"},{"key":"348_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","volume":"28","author":"Y Ohkubo","year":"1995","unstructured":"Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995, 28: 103-117. 10.1016\/0168-8227(95)01064-K.","journal-title":"Diabetes Res Clin Pract"},{"key":"348_CR20","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, et al: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572.","journal-title":"N Engl J Med"},{"issue":"7","key":"348_CR21","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/ndt\/gfq199","volume":"25","author":"G Schernthaner","year":"2010","unstructured":"Schernthaner G, Ritz E, Schernthaner GH: Strict Glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?. Nephrol Dial Transplant. 2010, 25 (7): 2044-2047. 10.1093\/ndt\/gfq199. Epub 2010 Apr 12","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"348_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/j.ajkd.2009.10.064","volume":"55","author":"HS Chen","year":"2010","unstructured":"Chen HS, Wu TE, Lin HD, Jap TS, Hsiao LC, Lee SH, Lin SH: Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stage 3 and 4. Am J Kidney Dis. 2010, 55 (5): 867-874. 10.1053\/j.ajkd.2009.10.064. Epub 2010 Mar 3","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"348_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000287561","volume":"31","author":"BI Freedman","year":"2010","unstructured":"Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, Russell GB, Stratta RJ, Bleyer AJ: Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol. 2010, 31 (5): 375-379. 10.1159\/000287561. Epub 2010 Mar 19","journal-title":"Am J Nephrol"},{"key":"348_CR24","first-page":"254","volume":"26","author":"F Bonnet","year":"2000","unstructured":"Bonnet F, Cooper ME: Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes Metab. 2000, 26: 254-264.","journal-title":"Diabetes Metab"},{"key":"348_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.mol.0000137219.31407.16","volume":"15","author":"J Armitage","year":"2004","unstructured":"Armitage J, Bowman L: Cardiovascular outcomes among participants with diabetes in the recent large statin trials. Curr Opin Lipidol. 2004, 15: 439-446. 10.1097\/01.mol.0000137219.31407.16.","journal-title":"Curr Opin Lipidol"},{"key":"348_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2337\/diab.45.7.974","volume":"45","author":"PH Groop","year":"1996","unstructured":"Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR: Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes. 1996, 45: 974-979. 10.2337\/diabetes.45.7.974.","journal-title":"Diabetes"},{"key":"348_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0026-0495(96)90009-8","volume":"45","author":"GF Watts","year":"1996","unstructured":"Watts GF, Powrie JK, O\u2019Brien SF, Shaw KM: Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus. Metabolism. 1996, 45: 1101-1107. 10.1016\/S0026-0495(96)90009-8.","journal-title":"Metabolism"},{"key":"348_CR28","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/diacare.16.10.1376","volume":"16","author":"BA Coonrod","year":"1993","unstructured":"Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ: Predictors of microalbuminuria in individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications study. Diabetes Care. 1993, 16: 1376-1383. 10.2337\/diacare.16.10.1376.","journal-title":"Diabetes Care"},{"issue":"2","key":"348_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2337\/diacare.29.02.06.dc05-0809","volume":"29","author":"MC Thomas","year":"2006","unstructured":"Thomas MC, Forsblom C, Rosengard-Barlund M, et al: Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care. 2006, 29 (2): 317-322. 10.2337\/diacare.29.02.06.dc05-0809.","journal-title":"Diabetes Care"},{"issue":"10\u201311","key":"348_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.clinbiochem.2009.03.013","volume":"42","author":"CH Tseng","year":"2009","unstructured":"Tseng CH: Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem. 2009, 42 (10\u201311): 1019-1024. Epub 2009 Mar 24","journal-title":"Clin Biochem"},{"issue":"4","key":"348_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1053\/j.ajkd.2007.07.011","volume":"50","author":"JC Lo","year":"2007","unstructured":"Lo JC, Go AS, Chandra M, Fan D, Kaysen GA: GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007, 50 (4): 552-558. 10.1053\/j.ajkd.2007.07.011.","journal-title":"Am J Kidney Dis"},{"key":"348_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, et al: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004, 140: 167-174.","journal-title":"Ann Intern Med"},{"key":"348_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND: Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006, 290: 262-272. 10.1152\/ajprenal.00099.2005.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:41:50Z","timestamp":1548196910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-104","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]},"article-number":"104"}}